{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:46:56Z","timestamp":1761155216387,"version":"3.33.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[1987,7,1]],"date-time":"1987-07-01T00:00:00Z","timestamp":552096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1987,7,1]],"date-time":"1987-07-01T00:00:00Z","timestamp":552096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1987,7]]},"DOI":"10.1136\/ard.46.7.555","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"555-558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Polyarthritis and angioimmunoblastic lymphadenopathy."],"prefix":"10.1016","volume":"46","author":[{"given":"N.J","family":"McHugh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.J","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J","family":"Landreth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.R","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref_1","first-page":"803","article-title":"Angioimmunoblastic lymphadenopathy. Diagnosis and clinical course","volume":"59","author":"Frizzera, G.; M, Moran E.; Rappaport, H.","year":"1975","unstructured":"Frizzera G, Moran E M, Rappaport H. Angioimmunoblastic lymphadenopathy. Diagnosis and clinical course. Am J Med 1975; 59: 803-18.","journal-title":"Am J Med"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/1097-0142(197808)42:2<447::AID-CNCR2820420211>3.0.CO;2-L","article-title":"Angioimmunoblastic lymphadenopathy. A T-cell deficiency","volume":"42","author":"A, Kosmidis P.; R, Axelrod A.; C, Palacus; M, Stahl","year":"1978","unstructured":"Kosmidis P A, Axelrod A R, Palacus C, Stahl M. Angioimmunoblastic lymphadenopathy. A T-cell deficiency. Cancer 1978; 42: 447-52.","journal-title":"Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM197501022920101","article-title":"Immunoblastic lymphadenopathy. Hyperimmune entity resembling Hodgkin's disease","volume":"292","author":"J, Lukes R.; H, Tindle B.","year":"1975","unstructured":"Lukes R J, Tindle B H. Immunoblastic lymphadenopathy. Hyperimmune entity resembling Hodgkin's disease. N Engl J Med 1975; 292: 1-8.","journal-title":"N Engl J Med"},{"key":"ref_4","first-page":"151","article-title":"Angioimmunoblastic lymphadenopathy: report of 10 cases and review of literature","volume":"48","author":"H, Cullen M.; G, Stansfeld A.; D, Oliver R.T.; A, Lister T.; S, Malpas J.","year":"1979","unstructured":"Cullen M H, Stansfeld A G, Oliver R T D, Lister T A, Malpas J S. Angioimmunoblastic lymphadenopathy: report of 10 cases and review of literature. Q J Med 1979; 48: 151-77.","journal-title":"Q J Med"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.1780220816","article-title":"Immunoblastic sarcoma with features of Sjogren's syndrome and systemic lupus erythematosus in a patient with immunoblastic lymphadenopathy","volume":"22","author":"A, Pierce D.; R, Stern; R, Jafle; J, Rutman; N, Tales","year":"1979","unstructured":"Pierce D A, Stern R, Jafle R, Rutman J, Tales N. Immunoblastic sarcoma with features of Sjogren's syndrome and systemic lupus erythematosus in a patient with immunoblastic lymphadenopathy. Arthritis Rheum 1979; 22: 911-6.","journal-title":"Arthritis Rheum"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/ard.42.5.516","article-title":"Arthritis and angioimmunoblastic lymphadenopathy","volume":"42","author":"G, Davies P.; N, Fordham J.","year":"1983","unstructured":"Davies P G, Fordham J N. Arthritis and angioimmunoblastic lymphadenopathy. Ann Rheum Dis 1983; 42: 516-8.","journal-title":"Ann Rheum Dis"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/art.1780251215","article-title":"Polyarthritis in immunoblastic lymphadenopathy","volume":"25","author":"Raskin R J, Tesar J T, Lawless 0 J","year":"1982","unstructured":"Raskin R J, Tesar J T, Lawless 0 J. Polyarthritis in immunoblastic lymphadenopathy. Arthritis Rheum 1982; 25: 1481-5.","journal-title":"Arthritis Rheum"},{"key":"ref_8","first-page":"1081","article-title":"Levamisole in angioimmunoblastic lymphadenopathy","volume":"i:","author":"C, Bensa J.; J, Fauve; H, Martin; J, Setto J.; R, Schafier","year":"1976","unstructured":"Bensa J C, Fauve J, Martin H, Setto J J, Schafier R. Levamisole in angioimmunoblastic lymphadenopathy. Lancet 1976; i: 1081.","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/ard.39.4.406","article-title":"Angioimmunoblastic lymphadenopathy associated with polyarthritis","volume":"39","author":"S, Rothwell R.; J, Mant M.; P, Davis","year":"1980","unstructured":"Rothwell R S, Mant M J, Davis P. Angioimmunoblastic lymphadenopathy associated with polyarthritis. Ann Rheum Dis 1980; 39: 406-9.","journal-title":"Ann Rheum Dis"},{"key":"ref_10","first-page":"129","article-title":"The leukaemic cell","author":"Calorsky, D.","year":"1981","unstructured":"Calorsky D. The leukaemic cell. Edinburgh: ChurchillLivingstone, 1981; 129-83."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI109260","article-title":"Decreased circulating thymus derived cells with receptors for the FC portion of immunoglobulin G in systemic lupus erythematosus","volume":"62","author":"Alarcon-Segovia, D.; Ruiz-Arguelles, A.","year":"1978","unstructured":"Alarcon-Segovia D, Ruiz-Arguelles A. Decreased circulating thymus derived cells with receptors for the FC portion of immunoglobulin G in systemic lupus erythematosus. J Clin Invest 1978; 62: 1390-1.","journal-title":"J Clin Invest"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1600-0609.1976.tb02838.x","article-title":"Restoration of a defective immunity by levamisole in a patient with immunoblastic lymphadenopathy","volume":"17","author":"Ellegaard, J.; M, Boesen A.","year":"1976","unstructured":"Ellegaard J, Boesen A M. Restoration of a defective immunity by levamisole in a patient with immunoblastic lymphadenopathy. Scand J Haematol 1976; 17: 36-43.","journal-title":"Scand J Haematol"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/1097-0142(19810115)47:2<266::AID-CNCR2820470210>3.0.CO;2-4","article-title":"The relationship between disease activity, treatment response, and immunologic reactivity in immunoblastic lymphadenopathy","volume":"47","author":"Brinker, H.; A, Birkeland S.","year":"1981","unstructured":"Brinker H, Birkeland S A. The relationship between disease activity, treatment response, and immunologic reactivity in immunoblastic lymphadenopathy. Cancer 1981; 47: 266-71.","journal-title":"Cancer"},{"key":"ref_14","first-page":"200","article-title":"Angio-immunoblastic lymphadenopathy","volume":"62","author":"Jacobs, P.; B, Kahn L.; S, King H.","year":"1982","unstructured":"Jacobs P, Kahn L B, King H S. Angio-immunoblastic lymphadenopathy. S Afr Med J 1982; 62: 200-2.","journal-title":"S Afr Med J"},{"issue":"4","key":"ref_15","first-page":"31","article-title":"Experience and recommendations for treatment schedule of levamisole in rheumatoid arthritis","volume":"5","author":"M, Veys E.; H, Mielants","year":"1978","unstructured":"Veys E M, Mielants H. Experience and recommendations for treatment schedule of levamisole in rheumatoid arthritis. J Rheumatol 1978; 5 (suppl 4): 31-41.","journal-title":"J Rheumatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724124545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724124545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.46.7.555","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T05:55:49Z","timestamp":1737525349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724124545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,7]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1987,7]]}},"alternative-id":["S0003496724124545"],"URL":"https:\/\/doi.org\/10.1136\/ard.46.7.555","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[1987,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyarthritis and angioimmunoblastic lymphadenopathy.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.46.7.555","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1987 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}